NOTIFICATION OF MAJOR INTERESTS IN SHARES
(1). Identity of the issuer or the underlying issuer of existing shares to
which voting rights are attached (ii):
BlackRock North American Income Trust plc
(2). Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights: (X)
An acquisition or disposal of qualifying financial instruments which may result
in the acquisition of shares already issued to which voting rights are
attached: ()
An acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
(3). Full name of person(s) subject to the notification obligation (iii):
BlackRock Investment Management (UK) Limited
(4). Full name of shareholder(s) (if different from 3.) (iv):
Nutraco Nominees Limited (on behalf of the BlackRock Savings Plan & ISA)
(5). Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):
Not notified
(6). Date on which issuer notified:
Not notified
(7). Threshold(s) that is/are crossed or reached:
n/a
(8). Notified details:
A: Voting rights attached to shares (viii) (ix)
Class/type of shares (if possible using the ISIN code): Ord £0.01 /
GB00B7W0XJ61
Situation previous to the triggering transaction(vi):
Number of Shares: 123,789
Number of Voting rights(viii): 123,789 (see additional information)
Resulting situation after the triggering transaction(vii):
Number of shares:
Direct: n/a
Number of voting rights (ix):
Direct (x):
Indirect (xi): 128,681
% of voting rights(x):
Direct:
Indirect: 0.1%
B. Qualifying Financial Instruments
Resulting situation after the triggering transaction (xii):
Type of financial instrument:
Expiration date (xiii):
Exercise/Conversion Period/Date (xiv):
Number of voting rights that may be acquired if the instrument is exercised/
converted:
% of voting rights:
C. Financial Instruments with similar economic effect to Qualifying Instruments
(xv), (xvi)
Resulting situation after the triggering transaction:
Type of financial instrument:
Exercise Price:
Expiration date (xvii):
Exercise/Conversion Period/Date (xviii):
Number of voting rights instrument refers to:
% of voting rights (xix) (xx):
Nominal:
Delta:
Total (A + B + C):
Number of voting rights: 128,681
% of voting rights: 0.1%
(9). Chain of controlled undertakings through which the voting rights and/or
the financial instruments are effectively held, if applicable (xv):
Proxy Voting:
(10). Name of the proxy holder:
Nutraco Nominees Limited
(11). Number of voting rights proxy holder will cease to hold:
n/a
(12). Date on which proxy holder will cease to hold voting rights:
n/a
(13). Additional information:
These shares are held on behalf of participants in the BlackRock Investment
Trust savings products. BlackRock Investment Management (UK) Limited has a
notifiable interest in these shares because, in certain circumstances and
subject to certain limitations agreed with the Takeover Panel to ensure
compliance with the Takeover Code, BlackRock is entitled to exercise the voting
rights attached to these shares if the relevant plan participants do not do so.
(14). Contact name:
C Driscoll
For BlackRock Investment Management (UK) Limited
Secretary
(15). Contact telephone number:
020 7743 2427
2 January 2014
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.